Corteva

Corteva's 15min chart sees KDJ Golden Cross, Bullish Marubozu

Corteva: Citigroup Keeps Neutral Rating, Raises Price Target to $80

Corteva Downgraded by J.P. Morgan to Neutral on Valuation Concerns

Corteva: RBC Capital Keeps Outperform, Raises PT to $89 from $80.

Corteva: Wells Fargo Keeps Overweight, Raises PT to $85 from $77

Catalyst<ul> <li>Most analysts rate CTVA Buy or Strong Buy, showing broad institutional optimism.</li></ul>Risk<ul> <li>Fund flows show negative trends across all order sizes, indicating declining institutional interest.</li></ul>

Key Factors

Corteva Inc. (CTVA) shares fell 3.53% on February 5, 2026, amid a downgrade to Neutral by JPMorgan and reduced trading volume of $0.42 billion. Corteva raised its 2026 operating EBITDA target to $4.1 billion, driven by its separation and licensing strategy, with a second-half 2026 spin-off planned. Corteva announced a dividend of $0.18 per share, yielding 1.0%, with expectations of 61.3% EPS growth next year and potential for future dividend increases.

CTVA News